Michael Narachi
Director/Board Member bij ULTRAGENYX PHARMACEUTICAL INC.
Vermogen: 1 M $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Emil Kakkis | M | 63 | 14 jaar | |
Daniel Welch | M | 66 | 9 jaar | |
Matthew Busch | M | 50 | 20 jaar | |
Shehnaaz Suliman | M | 52 | 5 jaar | |
Robert Eckert | M | 69 | 21 jaar | |
Matthew Fust | M | 59 | 10 jaar | |
Corazon Sanders | M | 67 | 3 jaar | |
Stephen J. Ubl | M | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 9 jaar |
Amrit Ray | M | 51 | 2 jaar | |
Deborah Dunsire | M | 61 | 7 jaar | |
Eric Crombez | M | - | 7 jaar | |
Joshua Higa | M | - | - | |
Mike Zahigian | M | - | 23 jaar | |
Ernie Meyer | M | 60 | 4 jaar | |
Richard A. Moscicki | M | 72 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 7 jaar |
Karah Parschauer | F | 46 | 8 jaar | |
Rodger Currie | M | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 8 jaar |
Dennis Huang | M | 59 | 9 jaar | |
Erik Harris | M | 54 | 7 jaar | |
Werner Baumann | M | 60 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 9 jaar |
Howard Horn | M | 47 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Frank Thomas | M | 54 | 6 jaar | |
Jerome Goldstein | M | 84 | 26 jaar | |
Thomas P. Lynch | M | 57 | 3 jaar | |
William Heiden | M | 64 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 8 jaar |
Graham Cooper | M | 54 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 9 jaar |
Peter Honig | M | 67 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 8 jaar |
Eckard Weber | M | 73 | 14 jaar | |
Scott A. Holmes | M | 50 | 4 jaar | |
Paul Cleveland | M | 67 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 1 jaar |
Patrick Mahaffy | M | 61 | 9 jaar | |
Krisztina Zsebo | M | 68 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 11 jaar |
Suzanne McDonald | F | 71 | - | |
Dennis D. Kim | M | 54 | 3 jaar | |
Michael Kelly | M | 67 | 14 jaar | |
Kathryn Falberg | F | 63 | 6 jaar | |
Marc M. P. de Garidel | M | 66 | 15 jaar | |
Joseph Hagan | M | 55 | 17 jaar | |
Barbara Dalton | M | 69 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 2 jaar |
Preston Klassen | M | 55 | 14 jaar | |
David W. Beier | M | 75 | 10 jaar | |
George Scangos | M | 76 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 3 jaar |
Robin D. Campbell | M | 69 |
Naryx Pharma, Inc.
Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA. | 18 jaar |
Madhavan Balachandran | M | 73 | 20 jaar | |
Gino Santini | M | 66 | 8 jaar | |
Lota Zoth | F | 64 | 7 jaar | |
Ramona Sequeira | F | 58 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 8 jaar |
Kevin Sharer | M | 76 | 20 jaar | |
Brian Pereira | M | 65 | 7 jaar | |
Giovanni Caforio | M | 59 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 5 jaar |
Eran Nadav | M | 55 | 4 jaar | |
Amy Sullivan | F | 54 | - | |
William P. Sheridan | M | 69 | 5 jaar | |
Susan Lundeen Smuck | F | 57 | 12 jaar | |
Monica Forbes | F | 49 | 4 jaar | |
Jin-Long Chen | M | 61 | 4 jaar | |
Diana McKenzie | F | 59 | 12 jaar | |
McDavid Stilwell | M | 53 | 4 jaar | |
Sean E. Harper | M | 61 | 16 jaar | |
Kathryn Carr Payne | F | - | 4 jaar | |
Parvinder S. Hyare | M | - | - | |
Vasant Prakash Gandhi | M | - | 5 jaar | |
Carl Johan Kördel | M | 62 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 2 jaar |
Rajiv De Silva | M | 58 | 1 jaar | |
Thomas Zindrick | M | 65 | 8 jaar | |
Robert Kaper | M | - | - | |
Robert M. Brenner | M | 56 | 11 jaar | |
John Moriarty | M | 56 | 6 jaar | |
Davey Scoon | M | 78 | 14 jaar | |
Bill Aliski | M | 75 | 11 jaar | |
Frank Herringer | M | 81 | 15 jaar | |
David J. Scott | M | 71 | - | |
Wendy Dixon | M | 68 | 6 jaar | |
Robert Perez | M | 59 | 11 jaar | |
Dan Turner | M | 62 | 7 jaar | |
Timothy Martin | M | 55 | 3 jaar | |
Elizabeth Reed | F | 53 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 2 jaar |
Edward C. English | M | 57 | 4 jaar | |
Scott B. Townsend | M | 56 | - | |
Lesley Russell | M | 63 | 10 jaar | |
Timothy G. Healey | M | 58 | - | |
Heather Turner | F | 51 | 8 jaar | |
Robert Hugin | M | 69 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 2 jaar |
Gil Omenn | M | 83 | 27 jaar | |
Joseph Vincent Bonventre | M | 74 | 5 jaar | |
James Sulat | M | 73 | 6 jaar | |
Brian H. Dovey | M | 83 | 14 jaar | |
Joseph Lacob | M | 68 | 8 jaar | |
Louis C. Bock | M | 59 | 13 jaar | |
J. Reason | M | 83 | 12 jaar | |
Clay Siegall | M | 64 | 7 jaar | |
Michael Powell | M | 69 | 8 jaar | |
Dan Omstead | M | 71 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 2 jaar |
Todd Foley | M | 52 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | 2 jaar |
Ron Zwanziger | M | 70 | 5 jaar | |
Barbara H. Deptula | F | 69 | 7 jaar | |
John Castellani | M | 73 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 5 jaar |
David Endicott | M | 58 | 6 jaar | |
Patricia A. Turney | F | 57 | 23 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Michael Narachi
- Persoonlijk netwerk